Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology.
Nat Commun
; 13(1): 634, 2022 02 02.
Article
in En
| MEDLINE
| ID: mdl-35110524
ABSTRACT
Back pain is a common and debilitating disorder with largely unknown underlying biology. Here we report a genome-wide association study of back pain using diagnoses assigned in clinical practice; dorsalgia (119,100 cases, 909,847 controls) and intervertebral disc disorder (IDD) (58,854 cases, 922,958 controls). We identify 41 variants at 33 loci. The most significant association (ORIDD = 0.92, P = 1.6 × 10-39; ORdorsalgia = 0.92, P = 7.2 × 10-15) is with a 3'UTR variant (rs1871452-T) in CHST3, encoding a sulfotransferase enzyme expressed in intervertebral discs. The largest effects on IDD are conferred by rare (MAF = 0.07 - 0.32%) loss-of-function (LoF) variants in SLC13A1, encoding a sodium-sulfate co-transporter (LoF burden OR = 1.44, P = 3.1 × 10-11); variants that also associate with reduced serum sulfate. Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfates
/
Intervertebral Disc Degeneration
/
Sodium Sulfate Cotransporter
/
Intervertebral Disc
/
Intervertebral Disc Displacement
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2022
Document type:
Article
Affiliation country:
Iceland